Raymond Isakov, MD
Plastic Surgery · Cleveland, OHNPI 1023081221
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 78 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 25.2% of the total.
Across 78 payments — averaging $67.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Mentor Worldwide LLC$622
- Integra Lifesciences Corporation$525
- Musculoskeletal Transplant Foundation Inc.$424
- Avita Medical Americas, LLC$406
- Axogen$184
- plus $2K from 14 others
What the payments were for
- Food & beverage$5,255100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 30 | $1,325 |
| Mentor Worldwide LLC | 12 | $622 |
| Integra Lifesciences Corporation | 5 | $525 |
| Musculoskeletal Transplant Foundation Inc. | 6 | $424 |
| Avita Medical Americas, LLC | 3 | $406 |
| Axogen | 2 | $184 |
| Polynovo North America LLC | 2 | $179 |
| TELA Bio, Inc. | 1 | $171 |
| W. L. Gore & Associates, Inc. | 1 | $169 |
| Aroa Biosurgery Incorporated | 1 | $166 |
| Smith+Nephew | 2 | $157 |
| Dilon Technologies, Inc. | 2 | $146 |
| Baxter Healthcare | 1 | $145 |
| Organogenesis Inc. | 1 | $124 |
| Convatec Inc. | 1 | $124 |
| Biotissue Holdings Inc. | 2 | $122 |
| Teleflex LLC | 1 | $112 |
| Boston Scientific | 1 | $76 |
| Johnson & Johnson | 2 | $47 |
| Solventum Corporation | 2 | $31 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTEGRA$1,066
- NATRELLE SALINE-FILLED BREAST IMPLANTS$562
- INTEGRA DERMAL REGENERATION TEMPLATE$450
- RECELL$406
- OMNIGRAFT$285
- SURGIMEND$285
- BOTOX$242
- MENTOR MemoryGel Resterilizable Gel Sizer$232
- OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$171
- GORE ENFORM Preperitoneal Biomaterial$169
- PRIMATRIX$165
- Novosorb BTM$151
- MENTOR CPX 2 Breast Tissue Expander$146
- ARTISS$145
- PICO 7 Single Use Negative Pressure Wound Therapy$140
- ALLODERM$131
- PuraPly$124
- AQUACEL Ag Extra$124
- AVANCE NERVE GRAFT$121
- AxoGuard Nerve Connector$121
How this compares
$5,255 in reported general payments places this provider in the 70th percentile of 191 plastic surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other plastic surgery in Cleveland
- Christopher SurekCleveland$1M
- Risal DjohanCleveland$330K
- Brian GastmanCleveland$88K
- Anthony TufaroCleveland$56K
- Maria SiemionowCleveland$28K
- Sarah BishopCleveland$24K
- Rachel AliottaCleveland$14K
- Meenakshi RajanCleveland$14K
- Donald HarveyCleveland$9K
- Jacob GrowCleveland$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.